Antibody for targeting cancers characterized by increased iron uptake
- 總結
- Nicole Suciu-Foca, Ph.D.
- 技術優勢
- Relevant to orphan diseases like Adult T Cell Leukemia and Mantle Cell LymphomaSpecifically targets cancer cells over healthy cellsTech Ventures Reference: IR CU14351Patent Information:Patent Pending
- 技術應用
- Cancer immunophenotyping In vitro sorting (e.g. using flow cytometry) of cells with TfR1 overexpression from healthy cellsTreatment of cancers characterized by TfR1 overexpressionIron replacement in pregnant womenTreatment for neurodegenerative diseases like Alzheimer's and Parkinson's
- 詳細技術說明
- Nicole Suciu-Foca, Ph.D.
- *Abstract
-
None
- *Inquiry
- Sara GusikColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- CU14351
- *Principal Investigation
-
- *Publications
- Tortorella S, Karagiannis TC. "Transferrin receptor-mediated endocytosis: a useful target for cancer therapy" J Membr. Biol. 2014 Feb 27;247(4):291-307.
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
